<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Medical Oncology

Research    Lung Cancer    Radiation    Medical Oncology    Targeted Therapies

Weeding the Garden: Fresh Evidence that Local Radiation Can Help Targeted Therapies in the Fight Against Lung Cancer

It’s been a dozen years since D. Ross Camidge, MD, PhD, of the University of Colorado Cancer Center and his colleagues first published on the use of tightly-focused radiation to attack isolated active cancer sites in lung cancer patients who otherwise were responding well to targeted therapies. In the years since, that breakthrough has transformed cancer care.


Author Mark Harden | Publish Date June 12, 2024
Full Story

Research    Lung Cancer    Medical Oncology

A Combination of Targeted Therapies Proves Effective Against Mutation-Driven Lung Cancer

Combining targeted therapies known as tyrosine kinase inhibitors (TKIs) can be an effective way to treat a mutation-driven form of lung cancer in cases where tumors develop resistance to treatment and where cancer has spread to other parts of the body, a University of Colorado Cancer Center member reports.


Author Mark Harden | Publish Date April 16, 2024
Full Story

Research    Breast Cancer    Drug Development    Medical Oncology

Two-Drug Combo Shows Promise as Treatment for Aggressive Form of Breast Cancer

Research led by University of Colorado Cancer Center members points to a combination of drugs as a potential treatment option for a type of aggressive breast cancer.


Author Mark Harden | Publish Date March 27, 2024
Full Story

Research    Head and Neck Cancer    Medical Oncology

CU Cancer Center Leaders Using a Molecule as a Weapon Against Cancer

After eight years of work by a pair of University of Colorado Cancer Center leaders on a new way to attack various cancers, the next stage in their quest to bring their therapy to patients is one of nine research endeavors receiving funding from the Anschutz Acceleration Initiative (AAI).


Author Mark Harden | Publish Date February 20, 2024
Full Story

Cancer    Magazine    Multidisciplinary Clinic    Medical Oncology

You Just Got a Cancer Diagnosis. Should You Get a Second Opinion?

A cancer diagnosis is a serious matter – which is why a patient who gets one should seriously consider getting a second opinion.


Author Mark Harden | Publish Date February 01, 2024
Full Story

Research    Breast Cancer    Medical Oncology

Tablets Show Promise as an Alternative to Chemotherapy in CU Cancer Center Member’s Breast Cancer Study

The focus of a University of Colorado Cancer Center member’s research career has been a quest for new, better therapies for patients with breast cancer. That quest by Elena Shagisultanova, MD, PhD, has resulted in a clinical trial pointing the way to an oral treatment that’s more tolerable than intensive chemotherapy for patients with a type of metastatic breast cancer that accounts for about 20% of cases among women under age 45.


Author Mark Harden | Publish Date January 29, 2024
Full Story

CU Cancer Center In the News

Cancer Network

Liso-cel May Show Benefit in Earlier Therapy Lines for Lymphoma Subgroups

news outletCancer Network
Publish DateJune 14, 2024

In a conversation at the 2024 European Hematology Association Congress, CU Cancer Center member Manali Kamdar, MD, discussed potential future research on lisocabtagene maraleucel (liso-cel; Breyanzi) for mantle cell lymphoma (MCL) and other lymphoma subgroups. She highlighted findings from the phase 1 TRANSCEND NHL 001 trial, noting improved efficacy and safety in patients with fewer prior therapies and non-refractory disease, suggesting liso-cel's utility in earlier treatment lines and specific lymphoma subgroups.

Full Story
Cancer Health

2024 Cancer Health 25: People Who Power Clinical Trials

news outletCancer Health
Publish DateJune 11, 2024

This year's Cancer Health 25 highlights the transformative power and promise of clinical trials. University of Colorado Cancer Center member Jessica McDermott, MD, MSCS, is leading clinical trials at both the CU Cancer Center and the Rocky Mountain Regional Veterans Affairs Medical Center. Additionally, she serves as the CU Cancer Center's deputy associate director for diversity and inclusion in clinical research.

Full Story
Cancer Network

Learning to “Aim High” Within Male-Dominated Fields in Public Health

news outletCancer Network
Publish DateJune 10, 2024

Cathy Bradley, PhD, deputy director of the University of Colorado Cancer Center and dean of the Colorado School of Public Health, is a trailblazer in health economics. At a Breaking Barriers: Women in Oncology discussion, she shared insights on overcoming challenges as a woman in a male-dominated field and discussed her research on the impact of employment on cancer patients' health insurance decisions.

Full Story
Washington Post

‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.

news outletWashington Post
Publish DateJune 07, 2024

A University of Colorado team lead by James DeGregori, PhD, deputy director of the University of Colorado Cancer Center, found in an April preprint report that SARS-CoV-2 and the flu virus can cause dormant cancer cells in mice to proliferate in the lungs.

Full Story